{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:54:53Z","timestamp":1778630093307,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1007\/s11926-996-0017-3","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T11:18:19Z","timestamp":1180783099000},"page":"453-458","source":"Crossref","is-referenced-by-count":27,"title":["Inflammatory conditions of the eye associated with rheumatic diseases"],"prefix":"10.1007","volume":"3","author":[{"given":"Natalie A.","family":"Afshari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehran A.","family":"Afshari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Stephen","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"17_CR1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bjo.80.4.332","volume":"80","author":"A Rothova","year":"1996","unstructured":"Rothova A, Suttorp-van Schulten MS, Frits Treffers W, et al.:Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 1996, 80:332\u2013336.","journal-title":"Br J Ophthalmol"},{"key":"17_CR2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00917828","volume":"18","author":"LB Ellwein","year":"1994","unstructured":"Ellwein LB, Fletcher A, Negrel AD, Thulasiraj RD: Quality of life assessment in blindness prevention interventions. Int Ophthalmol Clin 1994, 18:263\u2013268.","journal-title":"Int Ophthalmol Clin"},{"key":"17_CR3","first-page":"13","volume-title":"Uveitis Update","author":"E Vedot","year":"1984","unstructured":"Vedot E, Barth E, Billet P: Epidemiology of uveitis: preliminary results of a prospective study in Savoy. In Uveitis Update. Edited by Sarri KM. Amsterdam: Elsevier; 1984:13."},{"key":"17_CR4","first-page":"1198","volume-title":"Principles and Practice of Ophthalmology","author":"CS Foster","year":"1999","unstructured":"Foster CS, O\u2019Brien JM: Anterior uveitis. In Principles and Practice of Ophthalmology. Edited by Albert and Jakobiec. Philadelphia: WB Saunders; 1999:1198. This chapter describes disease entities, many of them rheumatologic, that lead to anterior uveitis."},{"key":"17_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004397-199803810-00003","volume":"38","author":"SL Harper","year":"1998","unstructured":"Harper SL, Foster CS: The ocular manifestations of rheumatoid disease. Int Ophthalmol Clin 1998, 38:1\u201319.","journal-title":"Int Ophthalmol Clin"},{"key":"17_CR6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF02204461","volume":"7","author":"GM Mody","year":"1988","unstructured":"Mody GM, Hill JC, Meyers OL: Keratoconjunctivitis sicca in rheumatoid arthritis. Clin Rheumatol 1988, 7:237.","journal-title":"Clin Rheumatol"},{"key":"17_CR7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/art.1780190214","volume":"19","author":"MA Alspaugh","year":"1976","unstructured":"Alspaugh MA, Talal N, Tan EM: Differentiation and characterization of autoantibodies and their antigens in Sjogren\u2019s syndrome. Arthritis Rheum 1976, 19:216\u2013222.","journal-title":"Arthritis Rheum"},{"key":"17_CR8","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1056\/NEJM197910043011405","volume":"301","author":"HM Moutsopoulos","year":"1979","unstructured":"Moutsopoulos HM, Mann DL: Genetic differences between primary and secondary sicca syndrome. N Engl J Med 1979, 301:761.","journal-title":"N Engl J Med"},{"key":"17_CR9","first-page":"742","volume":"94","author":"J Williamson","year":"1974","unstructured":"Williamson J: Incidence of eye disease in cases of connective tissue disease. Trans Ophthal Soc UK 1974, 94:742.","journal-title":"Trans Ophthal Soc UK"},{"key":"17_CR10","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0161-6420(94)31178-X","volume":"101","author":"M Sainz de la Maza","year":"1994","unstructured":"Sainz de la Maza M, Foster CS, Jabbur NS: Scleritis associated with rheumatoid arthritis and with other systemic immunemediated diseases. Ophthalmology 1994, 101:1281.","journal-title":"Ophthalmology"},{"key":"17_CR11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.60.3.163","volume":"60","author":"PG Watson","year":"1976","unstructured":"Watson PG, Hayreh SS: Scleritis and episcleritis. Br J Ophthalmol 1976, 60:163.","journal-title":"Br J Ophthalmol"},{"key":"17_CR12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00003226-199001000-00013","volume":"9","author":"J Tauber","year":"1990","unstructured":"Tauber J, Sainz de la Maza M: An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea 1990, 9:66.","journal-title":"Cornea"},{"key":"17_CR13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00003226-199507000-00010","volume":"14","author":"EM Messmer","year":"1995","unstructured":"Messmer EM, Foster CS: Destructive corneal and scleral disease associated with rheumatoid arthritis. Cornea 1995, 14:408.","journal-title":"Cornea"},{"key":"17_CR14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","volume":"130","author":"DA Jabs","year":"2000","unstructured":"Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 2000, 130:492. This paper provides an expert panel of physician recommendations of immunosuppressive drugs for treatment of patients with ocular inflammatory disorders. The side-effects and complications of corticosteroids support the rationale for immunosuppressive treatment. The treatment regimen with immunosuppressive agents should be individualized and the patients monitored regularly.","journal-title":"Am J Ophthalmol"},{"key":"17_CR15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/art.1780290216","volume":"29","author":"JT Cassidy","year":"1986","unstructured":"Cassidy JT, Levinson JE: A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 1986, 29:274.","journal-title":"Arthritis Rheum"},{"key":"17_CR16","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/0002-9394(75)90689-3","volume":"79","author":"LT Chylack","year":"1975","unstructured":"Chylack LT, Biengang DC: Ocular manifestations of juvenile rheumatoid arthritis. Am J Ophthalmol 1975, 79:1026.","journal-title":"Am J Ophthalmol"},{"key":"17_CR17","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0161-6420(87)80007-6","volume":"94","author":"MD Wolf","year":"1987","unstructured":"Wolf MD, Lichter PR, Ragsdale CG: Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology 1987, 94:1242.","journal-title":"Ophthalmology"},{"key":"17_CR18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/art.1780290615","volume":"29","author":"AM Rosenberg","year":"1986","unstructured":"Rosenberg AM, Oen KG: The relationship between ocular and articular disease activity in children with juvenile rheumatoid arthritis and associated uveitis. Arthritis Rheum 1986, 29:797.","journal-title":"Arthritis Rheum"},{"key":"17_CR19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/rheumatology\/31.9.633","volume":"31","author":"TR Southwood","year":"1992","unstructured":"Southwood TR, Ryder CA: Ophthalmological screening in juvenile arthritis: should the frequency of screening be based on the risk of developing chronic iridocyclitis? Br J Rheumatol 1992, 31:633.","journal-title":"Br J Rheumatol"},{"key":"17_CR20","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1001\/archopht.1977.04450100096010","volume":"95","author":"JJ Kanski","year":"1977","unstructured":"Kanski JJ: Anterior uveitis in juvenile rheumatoid arthritis. Arch Ophthalmol 1977, 95:1794.","journal-title":"Arch Ophthalmol"},{"key":"17_CR21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0889-857X(21)01001-2","volume":"15","author":"JM O\u2019Brien","year":"1989","unstructured":"O\u2019Brien JM, Albert DM: Therapeutic approaches for ophthalmic problems in juvenile rheumatoid arthritis. Rheum Dis Clin North Am 1989, 15:413.","journal-title":"Rheum Dis Clin North Am"},{"key":"17_CR22","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0161-6420(93)31568-X","volume":"100","author":"CS Foster","year":"1993","unstructured":"Foster CS, Barrett F: Cataract development and cataract surgery in patients with juvenile rheumatoid arthritisassociated iridocyclitis. Ophthalmology 1993, 100:809\u2013817.","journal-title":"Ophthalmology"},{"key":"17_CR23","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0140-6736(73)91090-8","volume":"2","author":"DA Brewerton","year":"1973","unstructured":"Brewerton DA, Caffrey M: Acute anterior uveitis and HLA27. Lancet 1973, 2:994.","journal-title":"Lancet"},{"key":"17_CR24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/03009749009097070","volume":"87","author":"A Linssen","year":"1990","unstructured":"Linssen A: B27+ disease versus B27-disease. Scand J Rheumatol 1990, 87:111.","journal-title":"Scand J Rheumatol"},{"key":"17_CR25","first-page":"270","volume-title":"Uveitis Fundaments and Clinical Practice","author":"RE Nusenblatt","year":"1996","unstructured":"Nusenblatt RE, Whitcup SM, Palestine AG: Uveitis Fundaments and Clinical Practice. St Louis: Mosby; 1996:270\u2013273."},{"key":"17_CR26","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1056\/NEJM196705252762102","volume":"276","author":"GL Spaeth","year":"1967","unstructured":"Spaeth GL: Corneal staining in systemic lupus erythematosus. N Engl J Med 1967, 276:1168.","journal-title":"N Engl J Med"},{"key":"17_CR27","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/bjo.56.11.800","volume":"56","author":"DH Gold","year":"1972","unstructured":"Gold DH, Morris DH, Henkind P: Ocular findings in systemic lupus erythematosus. Br J Ophthalmol 1972, 56:800.","journal-title":"Br J Ophthalmol"},{"key":"17_CR28","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/art.1780310904","volume":"31","author":"FJ Stafford-Brady","year":"1988","unstructured":"Stafford-Brady FJ: Lupus retinopathy: patterns, associations, and prognosis. Arthritis Rheum 1988, 31:1105.","journal-title":"Arthritis Rheum"},{"key":"17_CR29","first-page":"4563","volume-title":"Principles and Practice of Ophthalmology","author":"CS Foster","year":"1999","unstructured":"Foster CS: Systemic lupus erythematosus. In Principles and Practice of Ophthalmology. Edited by Albert and Jakobiec. Philadelphia: WB Saunders; 1999:4563. This chapter summarizes clinical findings of systemic lupus erythematosus and its ophthalmic findings in detail."},{"key":"17_CR30","first-page":"105","volume-title":"The Eye and Systemic Disease","author":"TP Kearns","year":"1975","unstructured":"Kearns TP: Collagen and rheumatic diseases: ophthalmic aspects. In The Eye and Systemic Disease. Edited by Masolf FA. St Louis: Mosby; 1975:105."},{"key":"17_CR31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ard.36.1.88","volume":"36","author":"RI Rynes","year":"1977","unstructured":"Rynes RI, Mika P, Bartholomew LE: Development of giant cell (temporal) arteritis in a patient \"adequately\" treated for polymyalgia rheumatica. Ann Rheum Dis 1977, 36:88.","journal-title":"Ann Rheum Dis"},{"key":"17_CR32","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1212\/WNL.10.5.490","volume":"10","author":"RW Hollenhorst","year":"1960","unstructured":"Hollenhorst RW, Rown JR, Wagener HP, Shick RM: Neurologic aspects of temporal. Neurology 1960, 10:490.","journal-title":"Neurology"},{"key":"17_CR33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00004397-200101000-00014","volume":"41","author":"NA Afshari","year":"2001","unstructured":"Afshari NA, Afshari MA, Lessell S: Temporal arteritis. Int Ophthalmol Clin 2001, 41:151\u2013158. This paper summarizes temporal arteritis and its ocular findings.","journal-title":"Int Ophthalmol Clin"},{"key":"17_CR34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.7326\/0003-4819-88-2-162","volume":"8","author":"KA Huston","year":"1978","unstructured":"Huston KA, Hunder FF, Lie JT, et al.: Temporal arteritis: a 25-year epidemiological, clinical and pathologic study. Ann Intern Med 1978, 8:162.","journal-title":"Ann Intern Med"},{"key":"17_CR35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0161-6420(83)34574-7","volume":"90","author":"CL Bullen","year":"1983","unstructured":"Bullen CL, Liesegang TJ, McDonald TJ, et al.: Ocular complications of Wegener\u2019s granulomatosis. Ophthalmology 1983, 90:279.","journal-title":"Ophthalmology"},{"key":"17_CR36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","volume":"98","author":"AS Fauci","year":"1983","unstructured":"Fauci AS, Haynes BF, Katz P, Wolff SM: Wegener\u2019s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983, 98:76\u201385.","journal-title":"Ann Intern Med"},{"key":"17_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archopht.1952.00920010004001","volume":"47","author":"GN Wise","year":"1952","unstructured":"Wise GN: Ocular periarteritis nodosa. Arch Ophthalmol 1952, 47:1\u201311.","journal-title":"Arch Ophthalmol"},{"key":"17_CR38","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bjo.50.11.651","volume":"50","author":"GJ Moore","year":"1966","unstructured":"Moore GJ, Sevel D: Corneo-scleral ulceration in periarteritis nodosa. Br J Ophthalmol 1966, 50:651\u2013655.","journal-title":"Br J Ophthalmol"},{"key":"17_CR39","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/archopht.1984.01040030592028","volume":"102","author":"JJ Purcell","year":"1984","unstructured":"Purcell JJ, Birkenkamp R, Tsai CC: Conjunctival lesions in periarteritis nodosa. Arch Ophthalmol 1984, 102:736.","journal-title":"Arch Ophthalmol"},{"key":"17_CR40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0002-9343(66)90023-4","volume":"41","author":"DL Dolan","year":"1966","unstructured":"Dolan DL, Lemmon GB Jr, Teitelbaum SL: Relapsing polychondritis chondritis. Am J Med 1966, 41:285\u2013299.","journal-title":"Am J Med"},{"key":"17_CR41","first-page":"96","volume":"24","author":"M Zeuner","year":"1997","unstructured":"Zeuner M, Straub RH, Rauh G, et al.: Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients. J Rheumatol 1997, 24:96\u2013101.","journal-title":"J Rheumatol"},{"key":"17_CR42","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0161-6420(86)33695-9","volume":"93","author":"BL Isaak","year":"1986","unstructured":"Isaak BL, Liesegang TJ, Michet CJ Jr: Ocular and systemic findings in relapsing polychondritis. Ophthalmology 1986, 93:681\u2013689.","journal-title":"Ophthalmology"},{"key":"17_CR43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0039-6257(98)00051-4","volume":"43","author":"EM Messmer","year":"1999","unstructured":"Messmer EM, Foster CS: Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol 1999, 43:379\u2013396. This paper describes in detail the clinical findings and management of vasculitic conditions such as rheumatoid arthritis, systemic lupus erythematosus, WG, RP, and PAN associated with peripheral ulcerative keratitis, as PUK may be the first sign of systemic necrotizing vasculitis.","journal-title":"Surv Ophthalmol"},{"key":"17_CR44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00004397-199603610-00013","volume":"36","author":"RB Bhisitkul","year":"1996","unstructured":"Bhisitkul RB, Foster CS: Diagnosis and ophthalmological features of Beh\u00c7et\u2019s disease. Int Ophthalmol Clin 1996, 36:127.","journal-title":"Int Ophthalmol Clin"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-996-0017-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-996-0017-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-996-0017-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T13:53:52Z","timestamp":1628949232000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-996-0017-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["17"],"URL":"https:\/\/doi.org\/10.1007\/s11926-996-0017-3","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}